# Efficacy and Safety of Sodium Heparin in Patients

> **NCT00894959** · PHASE3 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 104 (actual)

## Conditions studied

- Cardiac Surgery

## Interventions

- **BIOLOGICAL:** Heparin sodium Blausiegel 1
- **BIOLOGICAL:** Heparin sodium APP

## Key facts

- **NCT ID:** NCT00894959
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-09
- **Final completion:** 2011-12
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2013-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894959, "Efficacy and Safety of Sodium Heparin in Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00894959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*